GFPC network centers

The Groupe Français de Pneumo-Cancérologie (GFPC) is a prominent French cooperative research organization dedicated to advancing thoracic oncology. Established in 1988, the group manages a robust network of over 100 clinical centers, including general hospitals and private clinics, to conduct multicenter clinical trials. Their research primarily focuses on improving treatment outcomes for non-small cell lung cancer, small cell lung cancer, and mesothelioma. GFPC specializes in evaluating novel therapeutic modalities such as targeted therapies and immunotherapies through independent, investigator-initiated studies. By bridging the gap between academic research and clinical practice, the organization plays a vital role in defining new standards of care in respiratory oncology.